A. Gosselink

发表

The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2016, International journal of cardiology.

The prognostic importance of heart failure and age in patients treated with primary angioplasty

H. Suryapranata, J. Henriques, J. Hoorntje, 2003, European journal of heart failure.

The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients

J. Ottervanger, H. Suryapranata, M. de Boer, 2014, Netherlands Heart Journal.

Impact of ST-segment depression resolution on mortality after successful mechanical reperfusion in patients with ST-segment elevation acute myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention.

J. Ottervanger, H. Suryapranata, G. Borm, 2006, The American journal of cardiology.

Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2013, International journal of cardiology.

Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, Thrombosis and Haemostasis.

Ventricular fibrillation in acute myocardial infarction before and during primary PCI.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, International journal of cardiology.

Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, European heart journal.

Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol

J. Ottervanger, R. Hermanides, V. Roolvink, 2020, BMJ Open.

Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2014, Thrombosis and Haemostasis.

The effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practice

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2013, Thrombosis and Haemostasis.

Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Statin therapy and mortality in patients

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, Atherosclerosis.

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.

M. de Boer, C. Hamm, A. Mosterd, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial

J. Ottervanger, P. Stella, C. Hamm, 2010, Heart.

Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice.

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, International journal of cardiology.

Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, American heart journal.

Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients

J. Ottervanger, A. Elvan, F. Demirel, 2015, European heart journal. Acute cardiovascular care.

The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.

P. Stella, E. Boersma, C. Hamm, 2010, American heart journal.

Are patients with non-ST elevation myocardial infarction undertreated?

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2007, BMC cardiovascular disorders.

External validity of ST elevation myocardial infarction trials: The Zwolle studies

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention.

J. Ottervanger, H. Suryapranata, G. Borm, 2006, American heart journal.

Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2018, Netherlands Heart Journal.

A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.

H. Suryapranata, M. de Boer, J. Hoorntje, 2003, European heart journal.

Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2008, American heart journal.

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

J. Ottervanger, H. Suryapranata, M. de Boer, 2010 .

Mortality in patients with left ventricular ejection fraction

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, The American journal of cardiology.

NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: insight from the On-Time II trial.

E. Giannitsis, C. Hamm, R. Hermanides, 2020, American heart journal.

Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, International journal of cardiology.

Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Journal of Thrombosis and Thrombolysis.

Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, Journal of the American College of Cardiology.

Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty

S. Reiffers, A. Gosselink, A. Liem, 1998, Clinical cardiology.

Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, A. Maas, 2013, Diabetology & Metabolic Syndrome.

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores

J. Ottervanger, A. V. Van't Hof, Elvin Kedhi, 2016, Vascular health and risk management.

Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance

J. Ottervanger, H. Suryapranata, A. Elvan, 2012, Netherlands Heart Journal.

The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]

M. Nijsten, J. Ottervanger, H. Suryapranata, 2005, BMC medicine.

Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory

J. Ottervanger, H. Suryapranata, M. de Boer, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting

J. Ottervanger, P. Damman, R. D. de Winter, 2018, European heart journal. Cardiovascular pharmacotherapy.

Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI.

H. Suryapranata, C. Hamm, A. Mosterd, 2011, Journal of electrocardiology.

Poor outcome after recurrent acute myocardial infarction: a plea for optimal secondary prevention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, International journal of cardiology.

Marked reduction of early stent thrombosis with pre‐hospital initiation of high‐dose Tirofiban in ST‐segment elevation myocardial infarction

M. de Boer, C. Hamm, J. T. ten Berg, 2009, Journal of thrombosis and haemostasis : JTH.

Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, Heart.

Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-Segment–Elevation Myocardial Infarction and Signs of Heart Failure

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, Circulation.

Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial

J. Ottervanger, J. Hoorntje, J. Dambrink, 2012, Netherlands Heart Journal.

Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

P Myocardial Infarction yperglycemia Is an Important redictor of Impaired Coronary low Before Reperfusion Therapy in T-Segment Elevation Myocardial Infarction

J. Ottervanger, J. Hoorntje, F. Zijlstra, 2016 .

Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, Coronary artery disease.

Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty

J. Ottervanger, H. Suryapranata, Elvin Kedhi, 2020, European heart journal. Acute cardiovascular care.

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2015, Open Heart.

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, Journal of the American College of Cardiology.

Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial

J. Ottervanger, O. Klungel, D. Angiolillo, 2020, European heart journal. Cardiovascular pharmacotherapy.

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI

J. Ottervanger, H. Suryapranata, J. M. Berg, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, The Journal of laboratory and clinical medicine.

Paclitaxel‐eluting balloon versus everolimus‐eluting stent in patients with diabetes mellitus and in‐stent restenosis: Insights from the randomized DARE trial

M. Meuwissen, J. Piek, B. Claessen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, American heart journal.

Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry

J. Ottervanger, Elvin Kedhi, V. Roolvink, 2016, Netherlands Heart Journal.

Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Acute ST-segment elevation myocardial infarction associated with diclofenac-induced anaphylaxis: case report.

J. Ottervanger, J. D. de Groot, A. Gosselink, 2009, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2010 .

Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, Diabetes care.

Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, International journal of cardiology.

Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, Heart.

Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2010, The Journal of invasive cardiology.

Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion

J. Ottervanger, H. Suryapranata, G. De Luca, 2009, Journal of cardiovascular medicine.

Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2009, The American journal of cardiology.

The importance of patency of the infarct-related artery in treatment of patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 2003, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Thrombosis and Haemostasis.

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, European heart journal.

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, G. De Luca, M. de Boer, 2003, Journal of the American College of Cardiology.

Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2008, Thrombosis research.

Old Age and Outcome After Primary Angioplasty for Acute Myocardial Infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2010, Journal of the American Geriatrics Society.

Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a ‘real world’ prospective registry of the Zwolle Myocardial Infarction Study Group

J. Ottervanger, H. Bilo, R. Hermanides, 2020, European heart journal. Acute cardiovascular care.

Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age

J. Ottervanger, H. Suryapranata, A. Maas, 2013, European heart journal. Acute cardiovascular care.

The effect of pre‐hospital glycoprotein IIb–IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI

J. Ottervanger, C. Hamm, R. Hermanides, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.

J. Ottervanger, P. Damman, R. D. de Winter, 2018, European heart journal. Cardiovascular pharmacotherapy.

Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2008, The American journal of cardiology.

Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2009, Journal of Thrombosis and Thrombolysis.

Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, Heart.

Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.

J. Ottervanger, H. Suryapranata, Elvin Kedhi, 2016, The American journal of cardiology.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, M. de Boer, 2008 .

Angiography guided therapy in an all comer acute coronary syndrome patient population.

J. Ottervanger, H. Suryapranata, M. de Boer, 2013, International journal of cardiology.

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, R. Hermanides, 2016, Open Heart.

ACUTE ST-SEGMENT ELEVATION MYOCARDIAL

J. Ottervanger, A. Gosselink, J. Groot, 2009 .

A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial.

M. Beijk, J. Tijssen, R. D. de Winter, 2017, JACC. Cardiovascular interventions.

Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge

Felix Zijlstra, J. Ottervanger, H. Suryapranata, 2004, Circulation.

Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Prehospital triage in the ambulance reduces infarct size and improves clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, American heart journal.

Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.

J. Ottervanger, P. Stella, C. Hamm, 2012, The Journal of invasive cardiology.

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Vascular Health and Risk Management Dovepress Predictive Value of Nt-probnp for 30-day Mortality in Patients with Non-st-elevation Acute Coronary Syndromes: a Comparison with the Grace and Timi Risk Scores

J. Ottervanger, Elvin Kedhi, V. Roolvink, 2022 .

[Resuscitation for myocardial infarction and head injury: first the heart or first the head?].

A. Gosselink, J. Haringman, Peter T van Noord, 2014, Nederlands tijdschrift voor geneeskunde.

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2015, Open Heart.